Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GALVANO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.370
EU - Europa 1.280
AS - Asia 289
SA - Sud America 15
AF - Africa 11
OC - Oceania 9
Totale 6.974
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.358
IT - Italia 557
CN - Cina 190
DE - Germania 168
GB - Regno Unito 123
FI - Finlandia 87
IE - Irlanda 80
SE - Svezia 58
RU - Federazione Russa 41
RO - Romania 40
BE - Belgio 33
IN - India 27
UA - Ucraina 24
FR - Francia 21
IR - Iran 13
TR - Turchia 11
CA - Canada 10
EG - Egitto 10
AU - Australia 9
JP - Giappone 9
NL - Olanda 9
BR - Brasile 8
ES - Italia 8
HK - Hong Kong 8
AT - Austria 7
KR - Corea 5
MY - Malesia 5
CH - Svizzera 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CL - Cile 3
GR - Grecia 3
PE - Perù 3
TW - Taiwan 3
BD - Bangladesh 2
EE - Estonia 2
IL - Israele 2
MK - Macedonia 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
ID - Indonesia 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MC - Monaco 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 6.974
Salva come PNG Salva come JPEG
Città #
Fairfield 983
Ashburn 510
Chandler 502
Houston 434
Seattle 406
Woodbridge 406
Wilmington 345
Cambridge 335
Ann Arbor 262
Palermo 187
Medford 102
Des Moines 89
Altamura 78
Dublin 76
New York 69
Princeton 66
Lawrence 61
Ludwigshafen am Rhein 55
San Diego 55
Nanjing 43
Bremen 31
Brussels 30
Dearborn 30
Beijing 26
Helsinki 23
London 23
Falls Church 19
Boardman 17
Redwood City 17
Shenyang 17
Kumar 16
Hebei 14
Nanchang 14
Chicago 13
Milan 13
Rome 13
San Paolo di Civitate 12
Kilburn 11
Phoenix 11
Tulsa 11
Izmir 10
Jinan 10
Milazzo 10
Pune 10
Tehran 10
Ningbo 9
Saint Petersburg 9
Tappahannock 9
Changsha 8
Los Angeles 8
Munich 8
Norwalk 8
Orange 8
Aversa 7
Cairo 7
Tianjin 7
Frankfurt am Main 6
Jiaxing 6
Lucera 6
Washington 6
Central 5
Edinburgh 5
Hilliard 5
Jacksonville 5
Kuala Lumpur 5
Melbourne 5
Toronto 5
Turin 5
Zhengzhou 5
Cagliari 4
Council Bluffs 4
Guangzhou 4
Hanover 4
Islington 4
Lappeenranta 4
Agrigento 3
Amsterdam 3
Bologna 3
Caserta 3
Detroit 3
Hangzhou 3
Lima 3
Messina 3
Naples 3
Napoli 3
Sciara 3
Seongnam 3
Tokyo 3
Venice 3
Vienna 3
Wandsworth 3
Aci Sant'antonio 2
Acton 2
Alexandria 2
Antwerp 2
Berlin 2
Brzeg 2
Cairate 2
Caronno Pertusella 2
Casteltermini 2
Totale 5.722
Salva come PNG Salva come JPEG
Nome #
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 206
Dietary restriction: could it be considered as speed bump on tumor progression road? 205
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 191
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 186
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 185
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 184
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 179
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 177
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 165
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 160
Nintedanib in NSCLC: Evidence to date and place in therapy 159
Monoclonal antibodies in gastrointestinal cancers 158
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 156
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study 152
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 152
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 150
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 146
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 141
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 137
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 136
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 136
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 136
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis 135
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 132
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 129
COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients? 124
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 115
Clinical efficacy and safety of ezetimibe on major cardiovascular endpoints: Systematic review and meta-analysis of randomized controlled trials 113
Dose-finding study of oxaliplatin associated to capecitabinebased preoperative chemoradiotherapy in locally advanced rectal cancer 108
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 108
Ramucirumab and its use in gastric cancer treatment 102
Anti-angiogenic drugs for second-line treatment of NSCLC patients: Just new pawns on the chessboard? 101
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 100
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer 99
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 98
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 98
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal 89
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 82
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 82
2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 81
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 80
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 79
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 79
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups 79
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: Recommended schedule for expected activity and safety and phase II study 77
Impact of BMI on Preoperative Axillary Ultrasound Assessment in Patients With Early Breast Cancer 76
The use of same in chemotherapy-induced liver injury 73
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) 72
null 69
The emerging therapeutic landscape of alk inhibitors in non-small cell lung cancer 69
Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis 68
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 65
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results 62
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials 61
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 57
Indications for locoregional tumor therapies: CRC liver metastases 54
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 53
Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety 52
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer 47
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement 47
Liquid biopsy in colorectal carcinoma: the search for potential prognostic and predictive biomarkers 46
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 45
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 44
The treatment of medication-related osteonecrosis of the jaw (Mronj): A systematic review with a pooled analysis of only surgery versus combined protocols 41
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 39
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 37
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses 36
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 34
Second medical opinion in oncological setting 33
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 26
Accuracy evaluation of orthodontic movements with aligners: a prospective observational study. 23
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 22
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible 21
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies 21
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab 20
Editorial: The Effect of the COVID-19 Pandemic on Cancer Patients and Healthcare 20
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 19
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 19
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 18
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors 18
PROTACs: The Future of Leukemia Therapeutics 17
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study 16
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis 14
Liquid biopsy and immunotherapy: is all that glitter gold? 13
Network approach in liquidomics landscape 10
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier? 10
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 10
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 8
Future perspectives 8
Early detection screening: myth or reality? 7
Current clinically validated applications of liquid biopsy 6
Molecular tumor board 6
Liquid biopsy: a right tool in a right context? 6
null 3
Totale 7.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019270 0 0 0 0 0 0 0 0 0 0 134 136
2019/20201.853 127 72 98 342 180 245 163 135 148 136 159 48
2020/20211.393 90 49 151 69 137 89 137 114 115 214 145 83
2021/20221.177 119 209 74 39 63 60 59 67 100 140 91 156
2022/20231.448 148 279 32 186 122 225 85 129 116 20 78 28
2023/2024734 29 100 75 77 60 134 117 80 30 31 1 0
Totale 7.528